Impact of Atrial Fibrillation on Mortality, Stroke, and Medical Costs

Key Result

Prevention and treatment of atrial fibrillation in patients with cardiovascular disease can significantly reduce mortality, stroke incidence, and medical costs.

Key Points

• To assess how preventing and managing atrial fibrillation alongside associated cardiovascular disease influences mortality, stroke incidence, and healthcare expenditures.
• Evaluated therapeutic and preventive strategies for atrial fibrillation and co-occurring cardiovascular conditions.
• Analyzed clinical and economic outcomes related to patient mortality, stroke occurrences, and total healthcare expenditures.
• Preventing atrial fibrillation and treating affected individuals is associated with substantial reductions in overall mortality and stroke incidence.
• Optimizing management strategies for atrial fibrillation and related cardiovascular disease significantly lowers healthcare costs.